info icon

Any prescribed medicine buy

ANY_ATC

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Medicine purchases: ATC ANY

1 out of 7 registries used, show all original rules.

517176

4. Check minimum number of events

Min. number of events 3
517176

5. Include endpoints

None

517176

6. Filter based on genotype QC (FinnGen only)

517176

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF2

Case counts by codes

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 517176 292501 224675
Unadjusted period prevalence (%) 99.42 99.70 99.05
Median age at first event (years) 35.41 31.35 40.68

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
220
224
9.13
105.23
6.7
2.8
u/l
87.9
116.7
3.37
212
209
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
112
52
15.46
84.17
5.7
2.3
ng/l
59.7
40.0
0.34
74
30
(3044889) 12 lead EKG panel
179
184
8.02
82.70
3.9
1.8
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
208
259
7.07
81.79
3.6
1.7
mm/h
9.3
8.4
0.43
195
238
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
305
567
6.20
81.39
14.3
4.7
mg/l
26.6
28.7
0.31
248
319
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
242
392
5.82
72.70
5.4
1.7
mmol/mol
40.6
34.8
11.88
230
372
(3013826) Glucose [Moles/volume] in Serum or Plasma
195
257
6.40
71.59
5.2
6.1
mmol/l
6.5
5.5
7.64
183
226
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
252
432
5.63
71.05
4.2
1.9
mu/l
2.0
2.0
0.25
233
402
(3020564) Creatinine [Moles/volume] in Serum or Plasma
316
686
5.33
67.84
15.3
3.7
umol/l
80.6
66.2
7.76
316
686
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
206
309
5.71
65.92
3.7
1.6
pmol/l
15.0
14.4
1.96
188
273
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
317
704
5.19
65.66
9.2
2.8
u/l
26.9
26.8
0.03
309
668
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
248
447
5.24
65.09
12.1
3.0
ml/min/173m2
85.6
97.6
8.22
205
299
(40761511) CBC panel - Blood by Automated count
318
716
5.12
64.47
13.7
4.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
71
21
22.21
62.75
4.0
1.2
mg/mmol
12.2
32.8
0.31
45
13
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
128
120
7.79
62.06
4.9
1.8
ug/l
2.8
2.3
0.34
116
108
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
252
478
4.99
61.78
4.2
1.7
mmol/l
5.9
5.4
8.35
232
448
(3032080) INR in Blood by Coagulation assay
113
91
8.81
61.21
10.5
2.8
inr
1.2
1.2
0.02
34
25
(3037467) Urinalysis macro (dipstick) panel - Urine
199
309
5.39
60.72
4.6
2.5
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
178
248
5.76
60.71
7.9
4.6
e9/l
3.9
3.9
0.00
153
191
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
260
524
4.76
58.71
3.7
1.8
mmol/l
1.2
1.1
1.17
244
501
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
272
570
4.71
58.57
4.3
1.8
mmol/l
2.7
3.2
9.66
253
531
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
267
558
4.65
57.41
3.9
1.8
mmol/l
1.4
1.5
2.39
250
530
(3012516) Albumin [Mass/volume] in Urine
67
22
19.82
57.05
3.0
1.1
mg/l
1108.8
7670.6
0.66
40
12
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
266
562
4.57
56.14
4.0
1.8
mmol/l
4.5
5.0
11.28
250
535
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
80
42
12.68
55.78
4.5
5.2
ng/l
1447.1
1144.7
0.26
70
37
(3019198) Lymphocytes [#/volume] in Blood
162
229
5.45
53.71
5.7
3.9
e9/l
2.0
2.7
4.40
139
184
(3013115) Eosinophils [#/volume] in Blood
160
225
5.46
53.29
6.3
4.1
e9/l
0.2
0.2
0.13
136
177
(3001604) Monocytes [#/volume] in Blood
157
221
5.41
52.12
5.7
3.9
e9/l
0.6
0.6
0.95
132
175
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
103
91
7.83
51.71
4.6
1.6
%
21.0
23.0
0.33
49
24
(3002030) Lymphocytes/100 leukocytes in Blood
158
226
5.33
51.53
6.2
3.9
%
30.6
37.7
5.46
150
219
(3006315) Basophils [#/volume] in Blood
156
221
5.36
51.37
5.7
3.9
e9/l
0.0
0.0
0.55
132
174
(3018010) Neutrophils/100 leukocytes in Blood
155
220
5.34
50.89
5.9
3.9
%
54.3
47.4
4.77
147
215
(3019069) Monocytes/100 leukocytes in Blood
153
215
5.37
50.75
6.4
4.0
%
8.7
8.1
1.42
144
209
(3006504) Eosinophils/100 leukocytes in Blood
152
215
5.32
50.00
6.1
3.9
%
3.1
3.0
0.13
140
208
(3022096) Basophils/100 leukocytes in Blood
150
211
5.33
49.59
6.0
4.0
%
0.6
0.6
0.04
140
206
(3013512) EKG study
75
44
11.21
49.09
4.9
1.9
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
343
963
4.20
47.46
19.7
5.7
e9/l
242.4
259.3
4.08
336
874
(3026361) Erythrocytes [#/volume] in Blood
343
966
4.18
47.13
19.7
5.7
e12/l
4.5
4.7
3.38
337
874
(3010813) Leukocytes [#/volume] in Blood
343
969
4.16
46.81
19.9
5.7
e9/l
6.9
6.9
0.06
336
877
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
137
193
5.17
44.81
9.7
9.3
mmol/l
1.2
1.2
1.30
122
184
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
132
183
5.20
43.82
8.1
9.7
mmol/l
1.2
1.2
1.61
122
176
(3015377) Calcium [Moles/volume] in Serum or Plasma
81
66
8.12
42.83
3.6
1.4
mmol/l
2.4
2.4
0.18
73
57
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
78
62
8.28
41.95
2.9
1.6
ug/l
0.9
0.6
2.22
48
31
(3035350) Ketones [Presence] in Urine by Test strip
142
221
4.69
41.32
3.5
2.3
estimate
0.0
0.0
0.00
26
33
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
91
92
6.64
40.55
2.0
1.5
pmol/l
80.1
97.0
2.30
49
54
(40768804) Tissue Pathology biopsy report
98
108
6.16
40.49
2.0
1.7
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
55
26
13.38
40.03
1.7
1.2
pmol/l
386.5
456.4
0.44
47
20
(3021589) Normoblasts [#/volume] in Blood
142
227
4.56
39.93
10.4
5.8
e9/l
0.0
0.1
0.50
112
176
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
110
139
5.48
39.88
2.4
1.9
nmol/l
71.1
69.8
0.18
100
134
(3009508) Creatinine [Moles/volume] in Urine
78
67
7.65
39.56
2.8
3.3
mmol/l
8.4
8.5
0.04
70
62
(3023368) Bacteria identified in Blood by Culture
84
80
6.96
39.28
4.5
2.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
138
222
4.49
38.38
5.1
3.5
estimate
0.0
0.0
0.00
26
36
(3009261) Glucose [Presence] in Urine by Test strip
138
222
4.49
38.38
3.8
2.4
estimate
0.0
0.0
0.00
23
36
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
112
151
5.14
37.89
3.6
2.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
112
153
5.06
37.33
6.6
5.0
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
45
16
17.46
36.89
1.6
1.5
nmol/l
1105.2
1332.6
—
37
10
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
102
129
5.38
36.78
2.8
2.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
80
82
6.40
35.02
2.9
2.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
74
72
6.68
33.82
3.8
1.8
ph
7.4
7.4
—
15
7
(3015736) pH of Urine
109
160
4.67
33.33
3.0
1.9
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
67
60
7.17
32.71
2.7
2.0
mg/l
1.2
1.3
0.05
55
52
(3002582) Erythrocytes [#/volume] in Urine
95
128
4.97
31.83
2.5
2.8
e6/l
667.6
116.3
0.40
76
81
(3009542) Hematocrit [Volume Fraction] of Blood
280
818
3.12
31.81
14.5
5.8
%
39.7
40.1
0.37
233
715
(3018095) Leukocytes [#/volume] in Urine
106
159
4.53
31.51
3.3
3.4
e6/l
53.5
117.4
0.48
77
87
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
124
214
4.04
31.05
4.2
3.8
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
62
54
7.30
30.89
1.5
1.2
nmol/l
21.2
21.1
0.01
55
47
(3029937) Albumin [Presence] in Urine by Test strip
83
107
5.08
29.01
3.4
2.2
estimate
0.0
0.0
0.00
23
33
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
57
50
7.18
28.18
2.6
3.5
ng/l
205.9
447.8
0.63
37
30
(3001122) Ferritin [Mass/volume] in Serum or Plasma
120
227
3.63
26.20
2.5
2.5
ug/l
126.4
57.6
2.66
114
214
(3041096) Erythrocytes [Presence] in Urine by Automated
79
107
4.79
26.09
3.1
2.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
50
44
7.06
24.59
2.3
1.9
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
73
97
4.83
24.56
3.2
1.9
kg/l
1.0
1.0
0.44
11
15
(1761868) Lipid panel - Serum or Plasma
105
189
3.73
24.43
2.8
1.6
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
72
96
4.81
24.12
1.7
2.8
mg/l
2.9
2.8
0.08
67
88
(40768797) Stomach Pathology biopsy report
34
17
12.12
23.87
1.3
1.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
79
118
4.33
23.24
2.5
2.7
e6/l
0.2
0.2
0.31
61
70
(3042936) Bacteria identified in Isolate by Culture
44
36
7.52
22.84
1.8
1.9
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
79
122
4.18
22.29
2.4
2.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
58
68
5.35
22.13
3.5
2.0
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
35
22
9.65
21.65
1.2
1.0
u/ml
5.7
1.5
—
12
8
(40758558) Short blood count panel - Blood
74
112
4.23
21.36
8.6
4.4
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
37
28
8.03
20.28
4.9
2.3
u/l
241.1
244.0
0.05
37
28
(3022948) Iron [Moles/volume] in Serum or Plasma
46
47
6.02
19.92
2.3
2.0
umol/l
15.6
16.0
0.06
40
47
(3026782) Osmolality of Urine
54
66
5.09
19.72
2.8
2.8
mosm/kgh2o
582.5
551.3
0.31
49
56
(3022145) Colonoscopy Study observation
30
17
10.61
19.67
1.4
1.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
25
10
14.91
19.36
1.9
1.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
80
145
3.54
18.15
2.7
2.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
37
35
6.41
17.08
1.3
1.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
29
20
8.69
16.89
4.2
1.9
%
29.9
29.4
0.05
20
14
(3017732) Neutrophils [#/volume] in Blood
26
15
10.34
16.85
2.3
3.1
e9/l
3.5
4.9
—
20
10
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
39
40
5.93
16.79
1.8
1.8
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
69
119
3.66
16.72
1.4
1.3
g/l
2.3
1.7
1.00
39
52
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
80
154
3.32
16.56
1.7
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
45
55
5.01
16.39
2.3
1.8
ug/g
154.4
73.8
1.00
37
49
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
233
790
2.26
16.17
3.8
2.8
—
—
—
0
0
(3019225) pH of Specimen
22
11
11.85
15.35
6.3
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
54
83
4.02
15.17
1.8
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
36
38
5.72
15.09
1.7
1.7
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
69
128
3.39
15.04
1.2
1.4
u/ml
0.5
3.3
1.09
18
19
(3007853) Bacteria identified in Skin by Aerobe culture
37
42
5.33
14.49
1.7
1.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
34
36
5.69
14.21
5.5
11.5
mmol/l
0.6
0.7
0.02
25
24
(3011397) Hemoglobin [Presence] in Urine by Test strip
65
121
3.36
14.07
3.8
2.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
22
13
10.02
14.04
3.0
1.4
—
—
—
0
0
(4010399)
22
5
26.07
13.74
1.3
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
26
22
7.03
13.09
3.3
3.0
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
48
79
3.71
12.32
2.4
3.1
e6/l
0.3
1.4
1.01
32
39
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
52
91
3.51
12.27
1.8
1.6
mmol/l
1.6
1.5
0.04
46
82
(4035726)
23
19
7.17
11.78
1.4
1.2
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
21
16
7.74
11.40
2.3
3.2
e6/l
0.0
0.4
0.58
21
16
(3019060) Gas panel - Arterial blood
20
15
7.85
10.97
3.4
2.7
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
56
111
3.10
10.96
2.6
2.4
—
—
—
0
0
(3002256) Pathology report gross observation
30
37
4.84
10.80
1.2
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
44
77
3.46
10.37
2.3
2.6
e6/l
0.5
0.6
0.23
28
38
(3000492) Spirometry study
28
35
4.76
9.94
1.3
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
36
56
3.86
9.94
2.3
1.9
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
59
129
2.81
9.79
2.0
1.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
23
24
5.66
9.73
11.8
3.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
20
18
6.54
9.59
1.9
1.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
82
221
2.33
9.00
1.7
1.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
20
21
5.60
8.41
3.9
2.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
50
109
2.79
8.33
1.8
1.5
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
39
75
3.12
8.00
1.9
1.3
%
1.2
1.3
0.24
34
70
(46235355) HIV 1 and 2 tests - Meaningful Use set
83
239
2.17
7.78
2.0
1.7
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
19
22
5.06
7.30
1.3
2.2
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
17
19
5.23
6.75
6.8
19.5
%
1.4
1.1
0.53
17
19
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
15
15
5.83
6.58
1.9
1.2
nmol/l
37.6
38.5
0.06
15
15
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
17
20
4.97
6.43
6.8
18.8
%
0.7
0.7
0.04
17
20
(3012544) pH of Venous blood
37
79
2.80
6.41
6.0
6.4
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
37
80
2.76
6.27
6.0
6.2
mmol/l
1.8
0.7
1.03
27
57
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
15
16
5.46
6.22
9.0
21.9
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
41
95
2.58
6.13
9.6
9.9
mmol/l
1.3
-0.0
0.97
28
66
(3001019) Free T4 and TSH panel - Serum or Plasma
13
12
6.30
6.09
2.4
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
12
10
6.97
6.07
3.7
1.9
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
12
6
11.61
6.06
2.3
2.8
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
45
110
2.46
6.05
1.5
1.7
—
—
—
0
0
(1616796) Gas panel - Central venous blood
11
5
12.75
5.79
2.5
10.8
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
24
43
3.28
5.51
3.1
2.7
e9/l
59.8
62.9
0.18
18
25
(3000991) Gas panel - Venous blood
35
79
2.63
5.51
6.9
7.8
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
64
191
2.04
5.44
1.9
1.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
16
21
4.44
5.42
1.6
1.2
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
11
6
10.62
5.40
2.3
3.3
mmol/l
1.6
1.3
—
11
6
(3008898) HLA-B27 [Presence]
12
8
8.70
5.35
1.0
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
14
17
4.79
5.14
1.9
1.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
14
17
4.79
5.14
1.9
1.8
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
11
7
9.10
5.05
4.3
2.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
13
15
5.03
5.01
1.2
1.2
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
15
20
4.37
5.00
7.5
18.8
%
93.4
95.9
1.24
15
20
(3011985) Renin [Units/volume] in Plasma
6
0
+∞
4.96
1.2
0.0
mu/l
35.2
—
—
6
0
(3035933) Granulocytes/100 leukocytes in Blood
6
0
+∞
4.96
1.0
0.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
21
37
3.32
4.95
1.0
1.1
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
14
18
4.52
4.85
8.4
20.2
mmol/l
23.4
24.7
0.72
14
18
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
11
11
5.79
4.82
1.2
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
10
6
9.64
4.75
1.4
1.0
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
10
6
9.64
4.75
2.7
2.8
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
10
6
9.64
4.75
1.1
1.2
g/l
1.1
1.2
—
10
6
(3003327) Ova and parasites identified in Stool by Light microscopy
14
19
4.28
4.58
1.1
1.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
9
5
10.39
4.46
1.9
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
11
9
7.08
4.46
1.6
1.2
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
10
10
5.78
4.37
1.5
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
25
54
2.72
4.29
1.1
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
5
0
+∞
4.13
1.6
0.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
5
0
+∞
4.13
1.2
0.0
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
5
0
+∞
4.13
1.8
0.0
g/l
26.8
—
—
5
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
0
+∞
4.13
2.8
0.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
5
0
+∞
4.13
2.8
0.0
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
5
0
+∞
4.13
1.4
0.0
u/l
8.4
—
—
5
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
0
+∞
4.13
2.8
0.0
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
0
+∞
4.13
2.8
0.0
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
0
+∞
4.13
2.8
0.0
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
5
0
+∞
4.13
1.6
0.0
u/l
158.2
—
—
5
0
(40768443) Skin Pathology biopsy report
9
6
8.66
4.12
1.0
1.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
12
16
4.34
4.00
1.2
1.4
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
10
9
6.42
3.88
2.4
1.4
mmol/l
3.6
3.3
—
10
9
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
10
9
6.42
3.88
1.5
1.4
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
10
9
6.42
3.88
2.5
1.6
mg/l
288.2
573.3
—
10
9
(40768800) Prostate Pathology biopsy report
9
7
7.42
3.83
1.3
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
8
5
9.22
3.82
1.6
2.0
—
—
—
0
0
(3020891) Body temperature
10
12
4.81
3.71
2.9
4.7
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
9
8
6.49
3.56
1.4
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
49
156
1.87
3.51
1.8
1.6
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
17
34
2.91
3.35
2.8
2.1
u/l
11368.4
1994.4
—
5
17
(3024891) Influenza virus A+B Ag [Presence] in Specimen
11
16
3.97
3.33
1.7
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
9
9
5.77
3.32
1.8
4.7
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
8
7
6.58
3.24
1.0
1.1
g/l
0.2
0.2
—
8
7
(3008757) Leukocyte morphology finding [Identifier] in Blood
7
5
8.05
3.19
5.1
1.0
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
9
10
5.19
3.10
1.4
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
9
10
5.19
3.10
1.4
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
9
10
5.19
3.10
2.0
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
9
10
5.19
3.10
1.7
1.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
12
20
3.47
3.08
3.8
2.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
8
5.76
3.00
1.4
1.6
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
8
8
5.76
3.00
5.0
2.1
—
—
—
0
0
(3036489) Thrombin time
14
27
3.00
2.93
6.5
2.7
s
22.3
22.2
0.02
14
27
(3009445) Proteinase 3 Ab [Units/volume] in Serum
10
15
3.85
2.93
1.3
1.0
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
8
9
5.12
2.78
1.6
1.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
29
84
2.02
2.73
12.0
10.0
—
—
—
0
0
(44790048)
9
12
4.32
2.72
1.8
2.1
—
—
—
0
0
(44790047)
9
12
4.32
2.72
1.8
2.1
—
—
—
0
0
(44806118)
9
12
4.32
2.72
1.8
2.1
—
—
—
0
0
(44790049)
9
12
4.32
2.72
1.8
2.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
9
12
4.32
2.72
1.6
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
10
16
3.61
2.71
2.1
1.6
—
—
—
0
0
(4034850)
11
19
3.34
2.70
25.5
5.6
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
7
7
5.75
2.67
1.3
1.7
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
30
89
1.97
2.66
12.1
9.7
mmol/l
24.1
23.4
0.53
30
89
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
28
81
2.02
2.65
1.8
1.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
36
115
1.84
2.59
1.5
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
6
5
6.89
2.59
3.7
1.4
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
6
5
6.89
2.59
1.3
1.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
9
13
3.99
2.55
2.0
1.7
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
7
8
5.03
2.46
1.1
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
22
60
2.13
2.42
1.7
1.5
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
6
6
5.74
2.35
1.5
5.8
mmol/l
1.9
1.6
—
6
6
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
6
5.74
2.35
1.2
1.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
24
69
2.03
2.33
1.5
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
7
9
4.47
2.27
3.9
1.8
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
8
12
3.83
2.25
2.3
2.0
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
12
25
2.77
2.25
7.2
3.0
%
169.9
176.9
0.10
12
25
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
27
83
1.90
2.20
2.0
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
20
55
2.11
2.18
1.6
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
6
7
4.92
2.14
1.0
1.0
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
6
7
4.92
2.14
1.5
1.3
%
124.3
82.3
—
6
7
(3003740) Influenza virus B Ag [Presence] in Specimen
8
13
3.54
2.10
1.3
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
7
10
4.02
2.10
1.1
1.4
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
5
5
5.73
2.02
3.6
3.0
ug/l
19.3
21.6
—
5
5
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
9
17
3.05
2.00
1.7
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
12
27
2.56
1.98
1.4
1.1
miu/ml
224.4
340.4
—
5
12
(3002523) Influenza virus A Ag [Presence] in Specimen
8
14
3.28
1.96
1.3
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
8
4.30
1.95
1.3
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
7
11
3.65
1.94
2.0
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
29
96
1.76
1.91
1.7
1.4
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
8
15
3.06
1.84
1.9
1.1
—
—
—
0
0
(4268621)
5
6
4.77
1.81
2.6
2.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
6
9
3.82
1.79
3.0
20.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
8
16
2.87
1.72
1.3
2.8
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
7
13
3.09
1.67
1.0
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
10
3.44
1.64
1.2
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
6
10
3.44
1.64
4.5
1.9
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
5
7
4.09
1.63
1.4
1.1
%
95.0
73.6
—
5
7
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
7
4.09
1.63
1.0
1.4
—
—
—
0
0
(4306422)
5
7
4.09
1.63
1.4
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
14
38
2.13
1.60
1.4
1.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
22
71
1.80
1.60
1.7
1.8
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
7
15
2.68
1.45
1.4
1.0
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
12
32
2.16
1.44
9.0
5.5
%
88.3
89.9
0.07
12
32
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
15
45
1.92
1.36
1.1
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
15
45
1.92
1.36
1.6
1.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
12
33
2.09
1.35
1.4
1.4
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
5
9
3.18
1.34
1.4
3.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
13
2.64
1.28
1.8
1.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
20
68
1.70
1.26
1.5
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
11
31
2.04
1.18
2.8
1.7
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
16
52
1.77
1.17
1.8
1.3
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
16
52
1.77
1.17
1.8
1.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
16
52
1.77
1.17
1.8
1.3
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
16
52
1.77
1.17
1.8
1.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
14
44
1.83
1.14
1.6
1.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
14
44
1.83
1.14
1.6
1.3
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
17
57
1.72
1.13
1.8
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
13
41
1.82
1.05
1.1
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
11
33
1.92
1.02
1.5
1.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
14
2.45
0.98
3.8
2.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
6
15
2.29
0.94
1.5
1.2
—
—
—
0
0
(3022670) pH of Venous cord blood
6
16
2.15
0.90
1.0
1.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
10
31
1.85
0.86
1.6
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
5
12
2.38
0.79
1.2
1.0
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
5
12
2.38
0.79
1.2
1.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
5
12
2.38
0.79
1.2
1.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
16
59
1.56
0.79
1.1
1.2
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
5
13
2.20
0.76
1.4
3.0
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
13
2.20
0.76
2.2
1.7
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
12
43
1.60
0.67
1.3
1.8
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
16
62
1.48
0.66
1.1
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
16
62
1.48
0.66
1.2
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
16
62
1.48
0.66
1.1
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
16
63
1.46
0.62
1.1
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
7
28
1.43
0.46
1.0
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
15
64
1.34
0.41
2.1
2.0
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
6
0.00
0.22
0.0
1.0
—
—
—
0
0
(4038314)
0
6
0.00
0.22
0.0
1.2
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
6
0.00
0.22
0.0
1.5
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
8
0.00
0.21
0.0
1.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
12
57
1.20
0.16
1.2
1.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
37
0.77
0.08
1.4
1.5
—
—
—
0
0
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
9
48
1.07
0.07
1.0
1.0
mmol/l
17.0
19.7
—
9
48
(3006598) pH of Arterial cord blood
9
49
1.05
0.07
1.0
1.0
—
—
—
0
0
(42870560) Thyrotropin [Units/volume] in Cord blood
13
72
1.03
0.00
1.0
1.0
mu/l
11.8
8.1
0.81
13
64
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022229) Phosphate [Moles/volume] in Urine
0
5
0.00
0.00
0.0
2.8
—
20.5
—
0
5
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
7
44
0.90
0.00
1.3
1.5
—
—
—
0
0

Mortality – FinRegistry

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

Index endpoint: ANY_ATC – Any prescribed medicine buy

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).